Interferon alfa-2b biosimilar (Changchun Institute of Biological Products)

干扰素α2b生物类似药（长春生物制品）

Report date: 2026/05/22 20:01:29

Base Information

Drug NameInterferon alfa-2b biosimilar (Changchun Institute of Biological Products)
Drug Alias Namerecombinant human interferon alpha-2b干扰素α2b生物仿制药（长春生物制品）长生扶康Changshengfukang
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsChronic DiseaseHepatitis, ChronicHepatitis +[9] 
Global Approved IndicationsHepatitis, ChronicHepatitisLeukemia, Myelogenous, Chronic +[5] 
Approved Indications in ChinaHepatitis, ChronicHepatitisLeukemia, Myelogenous, Chronic +[5] 
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis, ChronicHepatitisLeukemia, Myelogenous, Chronic +[7] 
Inactive IndicationsChronic DiseaseVirus Diseases

Other Information

ATC CodeL03AB05
Related LinksN/A